Abstract
Homology modeling is a computational approach to generate three-dimensional structures of protein targets when experimental data about similar proteins are available. Although experimental methods such as X-ray crystallography and nuclear magnetic resonance spectroscopy successfully solved the structures of nearly 150,000 macromolecules, there is still a gap in our structural knowledge. We can fulfill this gap with computational methodologies. Our goal in this chapter is to explain how to perform homology modeling of protein targets for drug development. We choose as a homology modeling tool the program MODELLER. To illustrate its use, we describe how to model the structure of human cyclin-dependent kinase 3 using MODELLER. We explain the modeling procedure of CDK3 apoenzyme and the structure of this enzyme in complex with roscovitine.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Filgueira de Azevedo W Jr, dos Santos GC, dos Santos DM, Olivieri JR, Canduri F, Silva RG et al (2003) Docking and small angle X-ray scattering studies of purine nucleoside phosphorylase. Biochem Biophys Res Commun 309:923–928
da Silveira NJ, Arcuri HA, Bonalumi CE, de Souza FP, Mello IM, Rahal P et al (2005) Molecular models of NS3 protease variants of the hepatitis C virus. BMC Struct Biol 5:1
Silveira NJ, Uchôa HB, Pereira JH, Canduri F, Basso LA, Palma MS et al (2005) Molecular models of protein targets from Mycobacterium tuberculosis. J Mol Model 11:160–166
da Silveira NJ, Bonalumi CE, Uchõa HB, Pereira JH, Canduri F, de Azevedo WF (2006) DBMODELING: a database applied to the study of protein targets from genome projects. Cell Biochem Biophys 44:366–374
da Silveira NJF, Bonalumi CE, Arcuri HA, de Azevedo WF Jr (2007) Molecular modeling databases: a new way in the search of proteins targets for drug development. Curr Bioinforma 2:1–10
Marques MR, Pereira JH, Oliveira JS, Basso LA, de Azevedo WF Jr, Santos DS et al (2007) The inhibition of 5-enolpyruvylshikimate-3-phosphate synthase as a model for development of novel antimicrobials. Curr Drug Targets 8:445–457
Breda A, Basso LA, Santos DS, de Azevedo WF Jr (2008) Virtual screening of drugs: score functions, docking, and drug design. Curr Comput Aided Drug Des 4:265–272
de Azevedo WF Jr, Dias R (2008) Computational methods for calculation of ligand-binding affinity. Curr Drug Targets 9:1031–1039
Dias R, de Azevedo WF Jr (2008) Molecular docking algorithms. Curr Drug Targets 9:1040–1047
Arcuri HA, Zafalon GF, Marucci EA, Bonalumi CE, da Silveira NJ, Machado JM et al (2010) SKPDB: a structural database of shikimate pathway enzymes. BMC Bioinformatics 11:12
De Azevedo WF Jr (2010) MolDock applied to structure-based virtual screening. Curr Drug Targets 11:327–334
Ducati RG, Basso LA, Santos DS, de Azevedo WF Jr (2010) Crystallographic and docking studies of purine nucleoside phosphorylase from Mycobacterium tuberculosis. Bioorg Med Chem 18:4769–4774
Heberlé G, de Azevedo WF Jr (2011) Bio-inspired algorithms applied to molecular docking simulations. Curr Med Chem 18:1339–1352
Rocha BA, Delatorre P, Oliveira TM, Benevides RG, Pires AF, Sousa AA et al (2011) Structural basis for both pro- and anti-inflammatory response induced by mannose-specific legume lectin from Cymbosema roseum. Biochimie 93:806–816
Vianna CP, de Azevedo WF Jr (2012) Identification of new potential Mycobacterium tuberculosis shikimate kinase inhibitors through molecular docking simulations. J Mol Model 18:755–764
Moraes FP, de Azevedo WF Jr (2012) Targeting imidazoline site on monoamine oxidase B through molecular docking simulations. J Mol Model 18:3877–3886
Azevedo LS, Moraes FP, Xavier MM, Pantoja EO, Villavicencio B, Finck JA et al (2012) Recent Progress of molecular docking simulations applied to development of drugs. Curr Bioinforma 7:352–365
Coracini JD, de Azevedo WF Jr (2014) Shikimate kinase, a protein target for drug design. Curr Med Chem 21:592–604
de Avila MB, de Azevedo WF (2014) Data Mining of Docking Results. Application to 3-Dehydroquinate Dehydratase. Curr Bioinforma 9:361–379
Teles CB, Moreira-Dill LS, Silva Ade A, Facundo VA, de Azevedo WF Jr, da Silva LH et al (2015) A lupane-triterpene isolated from Combretum leprosum Mart. fruit extracts that interferes with the intracellular development of Leishmania (L.) amazonensis in vitro. BMC Complement Altern Med 15:165
de Azevedo WF Jr (2016) Opinion paper: targeting multiple cyclin-dependent kinases (CDKs): a new strategy for molecular docking studies. Curr Drug Targets 17:2
Canduri F, de Azevedo WF (2008) Protein crystallography in drug discovery. Curr Drug Targets 9:1048–1053
Fadel V, Bettendorff P, Herrmann T, de Azevedo WF Jr, Oliveira EB, Yamane T et al (2005) Automated NMR structure determination and disulfide bond identification of the myotoxin crotamine from Crotalus durissus terrificus. Toxicon 46:759–767
Heck GS, Pintro VO, Pereira RR, de Ávila MB, Levin NMB, de Azevedo WF (2017) Supervised machine learning methods applied to predict ligand-binding affinity. Curr Med Chem 24:2459–2470
Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H et al (2000) The Protein Data Bank. Nucleic Acids Res 28:235–242
Berman HM, Battistuz T, Bhat TN, Bluhm WF, Bourne PE, Burkhardt K et al (2002) The Protein Data Bank. Acta Crystallogr D Biol Crystallogr 58:899–907
Westbrook J, Feng Z, Chen L, Yang H, Berman HM (2003) The Protein Data Bank and structural genomics. Nucleic Acids Res 31(1):489–491
Ingwall RT, Scheraga HA, Lotan N, Berger A, Katchalski E (1968) Conformational studies of poly-L-alanine in water. Biopolymers 6:331–368
Lesk AM (1997) CASP2: report on ab initio predictions. Proteins Suppl 1:151–166
Zemla A, Venclovas C, Reinhardt A, Fidelis K, Hubbard TJ (1997) Numerical criteria for the evaluation of ab initio predictions of protein structure. Proteins Suppl 1:140–150
Kolinski A, Rotkiewicz P, Ilkowski B, Skolnick J (1999) A method for the improvement of threading-based protein models. Proteins 37:592–610
Rost B, Fariselli P, Casadio R (1996) Topology prediction for helical transmembrane proteins at 86% accuracy. Protein Sci 5:1704–1718
Xiang Z (2006) Advances in homology protein structure modeling. Curr Protein Pept Sci 7:217–227
Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ (1990) Basic local alignment search tool. J Mol Biol 215:403–410
Brünger AT (1992) Free R value: a novel statistical quantity for assessing the accuracy of crystal structures. Nature 355:472–475
Ramachandran GN, Ramakrishnan C, Sasisekharan V (1963) Stereochemistry of polypeptide chain configurations. J Mol Biol 7:95–99
Fanelli F, De Benedetti PG (2006) Inactive and active states and supramolecular organization of GPCRs: insights from computational modeling. J Comput Aided Mol Des 20:449–461
Wierenga RK, Borchert TV, Noble ME (1992) Crystallographic binding studies with triosephosphate isomerases: conformational changes induced by substrate and substrate-analogues. FEBS Lett 307:34–39
Sali A, Blundell TL (1993) Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 234:779–815
De Bondt HL, Rosenblatt J, Jancarik J, Jones HD, Morgan DO, Kim SH (1993) Crystal structure of cyclin-dependent kinase 2. Nature 363:595–602
Spring LM, Wander SA, Zangardi M, Bardia A (2019) CDK 4/6 inhibitors in breast cancer: current controversies and future directions. Curr Oncol Rep 21:25
Roskoski R Jr (2019) Cyclin-dependent protein serine/threonine kinase inhibitors as anticancer drugs. Pharmacol Res 139:471–488
Choo JR, Lee SC (2018) CDK4-6 inhibitors in breast cancer: current status and future development. Expert Opin Drug Metab Toxicol 14:1123–1138
Zardavas D, Pondé N, Tryfonidis K (2017) CDK4/6 blockade in breast cancer: current experience and future perspectives. Expert Opin Investig Drugs 26:1357–1372
Chen P, Lee NV, Hu W, Xu M, Ferre RA, Lam H et al (2016) Spectrum and degree of CDK drug interactions predicts clinical performance. Mol Cancer Ther 15:2273–2281
Canduri F, Perez PC, Caceres RA, de Azevedo WF Jr (2008) CDK9 a potential target for drug development. Med Chem 4:210–218
Krystof V, Cankar P, Frysová I, Slouka J, Kontopidis G, Dzubák P et al (2006) 4-arylazo-3,5-diamino-1H-pyrazole CDK inhibitors: SAR study, crystal structure in complex with CDK2, selectivity, and cellular effects. J Med Chem 49:6500–6509
Leopoldino AM, Canduri F, Cabral H, Junqueira M, de Marqui AB, Apponi LH et al (2006) Expression, purification, and circular dichroism analysis of human CDK9. Protein Expr Purif 47:614–620
Canduri F, de Azevedo WF Jr (2005) Structural basis for interaction of inhibitors with cyclin-dependent kinase 2. Curr Comput Aided Drug Des 1:53–64
Canduri F, Uchoa HB, de Azevedo WF Jr (2004) Molecular models of cyclin-dependent kinase 1 complexed with inhibitors. Biochem Biophys Res Commun 324:661–666
Filgueira de Azevedo W Jr, Gaspar RT, Canduri F, Camera JC Jr, Freitas da Silveira NJ (2002) Molecular model of cyclin-dependent kinase 5 complexed with roscovitine. Biochem Biophys Res Commun 297:1154–1158
de Azevedo WF Jr, Canduri F, da Silveira NJ (2002) Structural basis for inhibition of cyclin-dependent kinase 9 by flavopiridol. Biochem Biophys Res Commun 293:566–571
De Azevedo WF Jr, Mueller-Dieckmann HJ, Schulze-Gahmen U, Worland PJ, Sausville E, Kim SH (1996) Structural basis for specificity and potency of a flavonoid inhibitor of human CDK2, a cell cycle kinase. Proc Natl Acad Sci U S A 93:2735–2740
Kim SH, Schulze-Gahmen U, Brandsen J, de Azevedo Júnior WF (1996) Structural basis for chemical inhibition of CDK2. Prog Cell Cycle Res 2:137–145
Cui J, Yang Y, Li H, Leng Y, Qian K, Huang Q et al (2015) MiR-873 regulates era transcriptional activity and tamoxifen resistance via targeting CDK3 in breast cancer cells. Oncogene 34:3895–3907
Perez PC, Caceres RA, Canduri F, de Azevedo WF Jr (2009) Molecular modeling and dynamics simulation of human cyclin-dependent kinase 3 complexed with inhibitors. Comput Biol Med 39:130–140
Benson DA, Cavanaugh M, Clark K, Karsch-Mizrachi I, Lipman DJ, Ostell J et al (2013) GenBank. Nucleic Acids Res 41:36–42
Edgar RC (2004) MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res 32:1792–1797
De Azevedo WF, Leclerc S, Meijer L, Havlicek L, Strnad M, Kim SH (1997) Inhibition of cyclin-dependent kinases by purine analogues: crystal structure of human cdk2 complexed with roscovitine. Eur J Biochem 243:518–526
Thomsen R, Christensen MH (2006) MolDock: a new technique for high-accuracy molecular docking. J Med Chem 49:3315–3321
Abdelmonsef AH, Dulapalli R, Dasari T, Padmarao LS, Mukkera T, Vuruputuri U (2016) Identification of novel antagonists for Rab38 protein by homology modeling and virtual screening. Comb Chem High Throughput Screen 19:875–892
Filgueira de Azevedo W Jr, Canduri F, Simões de Oliveira J, Basso LA, Palma MS, Pereira JH et al (2002) Molecular model of shikimate kinase from Mycobacterium tuberculosis. Biochem Biophys Res Commun 295:142–148
Konno K, Hisada M, Fontana R, Lorenzi CC, Naoki H, Itagaki Y et al (2001) Anoplin, a novel antimicrobial peptide from the venom of the solitary wasp Anoplius samariensis. Biochim Biophys Acta 1550:70–80
Pereira JH, Canduri F, de Oliveira JS, da Silveira NJ, Basso LA, Palma MS et al (2003) Structural bioinformatics study of EPSP synthase from Mycobacterium tuberculosis. Biochem Biophys Res Commun 312:608–614
Rádis-Baptista G, Moreno FB, de Lima Nogueira L, Martins AM, de Oliveira Toyama D, Toyama MH et al (2006) Crotacetin, a novel snake venom C-type lectin homolog of convulxin, exhibits an unpredictable antimicrobial activity. Cell Biochem Biophys 44:412–423
Freitas PG, Elias TC, Pinto IA, Costa LT, de Carvalho PVSD, Omote DQ et al (2018) Computational approach to the discovery of phytochemical molecules with therapeutic potential targets to the PKCZ protein. Lett Drug Des Discov 15:488–499
Uchôa HB, Jorge GE, Freitas Da Silveira NJ, Camera JC Jr, Canduri F, De Azevedo WF Jr (2004) Parmodel: a web server for automated comparative modeling of proteins. Biochem Biophys Res Commun 325:1481–1486
Arcuri HA, Borges JC, Fonseca IO, Pereira JH, Neto JR, Basso LA et al (2008) Structural studies of shikimate 5-dehydrogenase from Mycobacterium tuberculosis. Proteins 72:720–730
Arcuri HA, Apponi LH, Valentini SR, Durigon EL, de Azevedo WF Jr, Fossey MA et al (2008) Expression and purification of human respiratory syncytial virus recombinant fusion protein. Protein Expr Purif 62:146–152
de Azevedo WF Jr (2010) Structure-based virtual screening. Curr Drug Targets 11:261–263
de Ávila MB, Bitencourt-Ferreira G, de Azevedo WF Jr (2018) Structural basis for inhibition of enoyl-[acyl carrier protein] reductase (InhA) from Mycobacterium tuberculosis. Curr Med Chem. https://doi.org/10.2174/0929867326666181203125229
Volkart PA, Bitencourt-Ferreira G, Souto AA, de Azevedo WF (2019) Cyclin-dependent kinase 2 in cellular senescence and cancer. A structural and functional review. Curr Drug Targets 20:716–726. https://doi.org/10.2174/1389450120666181204165344
Canduri F, Fadel V, Basso LA, Palma MS, Santos DS, de Azevedo WF Jr (2005) New catalytic mechanism for human purine nucleoside phosphorylase. Biochem Biophys Res Commun 327:646–649
Canduri F, Teodoro LG, Fadel V, Lorenzi CC, Hial V, Gomes RA et al (2001) Structure of human uropepsin at 2.45 A resolution. Acta Crystallogr D Biol Crystallogr 57:1560–1570
de Azevedo WF Jr, Dias R (2008) Experimental approaches to evaluate the thermodynamics of protein-drug interactions. Curr Drug Targets 9:1071–1076
Delatorre P, Rocha BA, Souza EP, Oliveira TM, Bezerra GA, Moreno FB et al (2007) Structure of a lectin from Canavalia gladiata seeds: new structural insights for old molecules. BMC Struct Biol 7:52
de Azevedo WF Jr, Canduri F, dos Santos DM, Pereira JH, Bertacine Dias MV, Silva RG et al (2003) Crystal structure of human PNP complexed with guanine. Biochem Biophys Res Commun 312:767–772
Canduri F, Perez PC, Caceres RA, de Azevedo WF Jr (2007) Protein kinases as targets for antiparasitic chemotherapy drugs. Curr Drug Targets 8:389–398
Dias MV, Borges JC, Ely F, Pereira JH, Canduri F, Ramos CH et al (2006) Structure of chorismate synthase from Mycobacterium tuberculosis. J Struct Biol 154:130–143
Dias MV, Ely F, Palma MS, de Azevedo WF Jr, Basso LA, Santos DS (2007) Chorismate synthase: an attractive target for drug development against orphan diseases. Curr Drug Targets 8:437–444
Silva RG, Pereira JH, Canduri F, de Azevedo WF Jr, Basso LA, Santos DS (2005) Kinetics and crystal structure of human purine nucleoside phosphorylase in complex with 7-methyl-6-thio-guanosine. Arch Biochem Biophys 442:49–58
Timmers LF, Caceres RA, Vivan AL, Gava LM, Dias R, Ducati RG et al (2008) Structural studies of human purine nucleoside phosphorylase: towards a new specific empirical scoring function. Arch Biochem Biophys 479:28–38
de Azevedo WF Jr (2011) Molecular dynamics simulations of protein targets identified in Mycobacterium tuberculosis. Curr Med Chem 18:1353–1366
de Azevedo WF Jr (2011) Protein targets for development of drugs against Mycobacterium tuberculosis. Curr Med Chem 18:1255–1257
Caceres RA, Saraiva Timmers LF, Dias R, Basso LA, Santos DS, de Azevedo WF Jr (2008) Molecular modeling and dynamics simulations of PNP from Streptococcus agalactiae. Bioorg Med Chem 16:4984–4993
Dias MV, Faím LM, Vasconcelos IB, de Oliveira JS, Basso LA, Santos DS et al (2007) Effects of the magnesium and chloride ions and shikimate on the structure of shikimate kinase from Mycobacterium tuberculosis. Acta Crystallogr Sect F Struct Biol Cryst Commun 63:1–6
de Azevedo WF Jr, Ward RJ, Canduri F, Soares A, Giglio JR, Arni RK (1998) Crystal structure of piratoxin-I: a calcium-independent, myotoxic phospholipase A2-homologue from Bothrops pirajai venom. Toxicon 36:1395–1406
Dias R, Timmers LF, Caceres RA, de Azevedo WF Jr (2008) Evaluation of molecular docking using polynomial empirical scoring functions. Curr Drug Targets 9:1062–1070
da Silveira NJ, Uchôa HB, Canduri F, Pereira JH, Camera JC Jr, Basso LA et al (2004) Structural bioinformatics study of PNP from Schistosoma mansoni. Biochem Biophys Res Commun 322:100–104
de Azevedo WF Jr, Dias R (2008) Evaluation of ligand-binding affinity using polynomial empirical scoring functions. Bioorg Med Chem 16:9378–9382
Bezerra GA, Oliveira TM, Moreno FB, de Souza EP, da Rocha BA, Benevides RG et al (2007) Structural analysis of Canavalia maritima and Canavalia gladiata lectins complexed with different dimannosides: new insights into the understanding of the structure-biological activity relationship in legume lectins. J Struct Biol 160:168–176
Canduri F, Fadel V, Dias MV, Basso LA, Palma MS, Santos DS et al (2005) Crystal structure of human PNP complexed with hypoxanthine and sulfate ion. Biochem Biophys Res Commun 326:335–338
Timmers LF, Pauli I, Caceres RA, de Azevedo WF Jr (2008) Drug-binding databases. Curr Drug Targets 9:1092–1099
Delatorre P, Rocha BA, Gadelha CA, Santi-Gadelha T, Cajazeiras JB, Souza EP et al (2006) Crystal structure of a lectin from Canavalia maritima (ConM) in complex with trehalose and maltose reveals relevant mutation in ConA-like lectins. J Struct Biol 154:280–286
Nolasco DO, Canduri F, Pereira JH, Cortinóz JR, Palma MS, Oliveira JS et al (2004) Crystallographic structure of PNP from Mycobacterium tuberculosis at 1.9A resolution. Biochem Biophys Res Commun 324:789–794
Arcuri HA, Canduri F, Pereira JH, da Silveira NJ, Camera Júnior JC, de Oliveira JS et al (2004) Molecular models for shikimate pathway enzymes of Xylella fastidiosa. Biochem Biophys Res Commun 320:979–991
Soares MB, Silva CV, Bastos TM, Guimarães ET, Figueira CP, Smirlis D et al (2012) Anti-Trypanosoma cruzi activity of nicotinamide. Acta Trop 12:224–229
Manhani KK, Arcuri HA, da Silveira NJ, Uchôa HB, de Azevedo WF Jr, Canduri F (2005) Molecular models of protein kinase 6 from Plasmodium falciparum. J Mol Model 12:42–48
Marques MR, Vaso A, Neto JR, Fossey MA, Oliveira JS, Basso LA et al (2008) Dynamics of glyphosate-induced conformational changes of Mycobacterium tuberculosis 5-enolpyruvylshikimate-3-phosphate synthase (EC 2.5.1.19) determined by hydrogen-deuterium exchange and electrospray mass spectrometry. Biochemistry 47:7509–7522
Cavada BS, Moreno FB, da Rocha BA, de Azevedo WF Jr, Castellón RE, Goersch GV et al (2006) cDNA cloning and 1.75 A crystal structure determination of PPL2, an endochitinase and N-acetylglucosamine-binding hemagglutinin from Parkia platycephala seeds. FEBS J 273:3962–3974
Moreno FB, de Oliveira TM, Martil DE, Viçoti MM, Bezerra GA, Abrego JR et al (2008) Identification of a new quaternary association for legume lectins. J Struct Biol 161:133–143
Xavier MM, Heck GS, de Avila MB, Levin NM, Pintro VO, Carvalho NL et al (2016) SAnDReS a computational tool for statistical analysis of docking results and development of scoring functions. Comb Chem High Throughput Screen 19:801–812
de Ávila MB, Xavier MM, Pintro VO, de Azevedo WF (2017) Supervised machine learning techniques to predict binding affinity. A study for cyclin-dependent kinase 2. Biochem Biophys Res Commun 494:305–310
Bitencourt-Ferreira G, de Azevedo WF Jr (2018) Development of a machine-learning model to predict Gibbs free energy of binding for protein-ligand complexes. Biophys Chem 240:63–69
Levin NMB, Pintro VO, Bitencourt-Ferreira G, Mattos BB, Silvério AC, de Azevedo WF Jr (2018) Development of CDK-targeted scoring functions for prediction of binding affinity. Biophys Chem 235:1–8
Acknowledgments
This work was supported by grants from CNPq (Brazil) (308883/2014-4). This study was financed in part by the Coordenação de Aperfeiçoamento de Pessoal de Nivel Superior—Brasil (CAPES)—Finance Code 001. GBF acknowledges support from PUCRS/BPA fellowship. WFA is a senior researcher for CNPq (Brazil) (Process Numbers: 308883/2014-4 and 309029/2018-0).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Bitencourt-Ferreira, G., de Azevedo, W.F. (2019). Homology Modeling of Protein Targets with MODELLER. In: de Azevedo Jr., W. (eds) Docking Screens for Drug Discovery. Methods in Molecular Biology, vol 2053. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-9752-7_15
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9752-7_15
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-4939-9751-0
Online ISBN: 978-1-4939-9752-7
eBook Packages: Springer Protocols